Evidence·Excretion / Persistence
ReportedClearance evidence
ATLXM0054250
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0054250
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0054250
Mild (CLcr 60-89 mL/min) or moderate (CLcr 30-59 mL/min) renal impairment has no effect on clearance of lanreotide in patients with GEP-NET based on population PK analysis which included 106 patients with mild and 59 patients with moderate renal impairment treated with SOMATULINE DEPOT.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
